Testostérone et santé métabolique et cardiovasculair de l’homme : Quelles preuves en 2010 ?

Abstract

In recent years the association between testosterone deficiency (TD) and insulin resistance, type 2 diabetes
and metabolic syndrome became glaring. Prospective studies have particularly shown that a
low testosterone (T) predicted later development of diabetes or metabolic syndrome.
Likewise type 2 diabetes and metabolic syndrome predict the development of TD. Cross-sectional studies
further suggest that both TD and type 2 diabetes and metabolic syndrome are associated with impaired erectile function, with decreased penile blood flow. In addition four studies with group
Recent control suggests that treatment with testosterone can significantly improve blood sugar control and insulin resistance.